Skip to main content

A long-lasting emerging epidemic of anthroponotic cutaneous leishmaniasis in southeastern Iran: population movement and peri-urban settlements as a major risk factor



Epidemics of cutaneous leishmaniasis (CL) are occurring more frequently and spreading faster and farther than before in many areas of the world. The present study aimed to assess a long-lasting emerging epidemic (2005–2019) of 5532 cases with anthroponotic CL (ACL) in peri-urban areas of Kerman city in southeastern Iran.


This descriptive-analytical study was carried out for 15 years in Kerman province, southeastern Iran. The data were passively obtained through the health surveillance system and the Kerman Leishmaniasis Research Center. Every subject was diagnosed using direct smear microscopy. The representative causative agent was further examined by ITS1-PCR, PCR-RFLP, 7SL RNA gene sequencing and phylogenetic analyses. For each subject, a case report form designating demographic and clinical data was recorded.


A different pattern of ACL incidence was found in peri-urban areas compared to that in the city of Kerman. The incidence rate of ACL cases has significantly increased (P < 0.001) from 2005 to 2016 in new settlements with a gradual decline after that. The overall average risk of contracting the disease was 7.6 times higher in peri-urban areas compared to Kerman city, an old endemic focus. All isolates consisting of six variants were confirmed to be Leishmania tropica. The overall pattern of the ACL infection indicates that the etiological agent of ACL is propagated and transmitted by the bite of female Phlebotomus sergenti sandflies from person to person from dissimilar clones as reflected by the complexity of the migrants’ backgrounds in the province.


The movement of populations and establishment of new settlements in peri-urban areas close to endemic areas are major risk factors for and are directly linked to CL. The underlying factors of this emerging ACL epidemic caused by L. tropica were disasters and droughts, among others. A robust commitment to a multilateral approach is crucial to make improvements in this area. This will require decisive coordinated actions through all governmental factions and non-governmental organizations. Furthermore, active and passive case detection strategies, early diagnosis, and effective treatment could help control the disease.


Leishmaniasis remains a serious concern among the most neglected and vector-borne diseases worldwide [1, 2]. There are several forms of classical and atypical leishmaniasis, among which three forms are principal: cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and visceral leishmaniasis (VL) [3]. The disease burden is not well known, but based on recent estimates, up to 1.3 million new cases of leishmaniasis, 12 million prevalence, and some 26,000–65,000 deaths in 101 countries and territories occur annually among a population of 1 billion at-risk individuals [3, 4]. However, the current actual burden is much greater than reported in the previous statistics. Due to confounding factors, ongoing conflict, consequent migration, and unprecedented environmental risks, new CL figures propose that this disease is a large-scale social and medical problem in the affected countries [5]. Etiological agents involve a digenetic life-cycle between an invertebrate vector, phlebotomine sandflies, and a vertebrate reservoir host, such as humans and suitable animals [6].

Cutaneous leishmaniasis is the most epidemic-prone disease, a common type, and a widely dispersed form with serious public health complications in 70 countries where nearly 95% of CL cases occur, mainly in the world's tropics, namely the Americas, Mediterranean countries, the Middle East, and Central Asia. Predictably, the WHO Eastern Mediterranean Region alone accounts for 70% of the new cases globally, and the remaining cases (30%) occur in other parts of the world. In 2017, it was reported that > 95% of the incidence occurred in Afghanistan, Syria, Algeria, Iran, Colombia, and Brazil [3]. Cutaneous leishmaniasis produces cutaneous lesions on naked areas of the body, which are often exposed to the bite of female sandflies. The disease is self-healing but causes life-long cutaneous scars, prominent disfigurement, severe disability, serious depression, and social stigmatization [1].

Currently, no approved and efficacious vaccine against leishmaniasis is available. The use of conventional drugs is not sufficient, although liposomal amphotericin B has previously been recommended [7]. Moreover, there is an effective personal control measure for leishmaniasis. In a village-based cohort study, Olyset® Plus, a novel long-lasting insecticidal net (LLIN), impregnated with 2% permethrin and piperonyl butoxide, was used against CL transmission. The protective efficacy level of LLIN was assessed to be 92.2% following 6 and 12 months of usage. The authors concluded that Olyset® Plus nets are an effective and durable personal protection measure to prevent sandfly bites in a hyperendemic area of Turkey [8].

The recent unprecedented national and global spread of CL has highlighted the challenges faced by many countries. Most vector-borne diseases (VBDs) such as CL can be prevented through vector control, but only if implemented effectively. This is, however, hampered by numerous challenges that include: lack of capacity and capability in programs, lack of a comprehensive national strategy, the absence of a legal framework for a vector control intervention toolbox, lack of community involvement, and ongoing environmental and social changes that result in the proliferation and geographical expansion of vectors [9]. However, the potential risk for the Leishmania species in the Mediterranean region is variable and reported predominantly in the June-October period. Therefore, the highest protective effect will be attained between 11 p.m. and 2 a.m., coinciding with the nocturnal pattern of female sandfly activity [10].

Global studies indicated numerous emerging CL outbreaks over the past years in different parts of the world, including Peru [11], Brazil [12, 13], Afghanistan [14], Libya [15], Syria [16], Iraq [17], Yemen [18], Sudan [19], Morocco [20], and Saudi Arabia [21]. The CL situation is probably similar in the countries neighboring Iran. Due to the ongoing civil war in Syria, many Syrians have fled to Turkey and other neighboring countries, contributing to a drastic increase in CL cases predominantly caused by L. tropica [22]. Turkey is a crossroad between the Asian countries and Europe. A recent survey by Özden and colleagues indicated that approximately 4 million Syrian refugees arrived in Turkey before 2013 [23, 24]. Millions of other Syrians crossed the border into Turkey, causing serious socioeconomic consequences and severe public impacts in this country, and then moved toward Europe [25]. Despite the relative reduction in VL patients, the number of CL cases has been rising, mainly because of escalation of transmission in rural communities and suburban areas of the cities and the deterioration of economic and social conditions in highly exposed populations in the world [6].

In Iran, two CL types, including anthroponotic CL (ACL) and zoonotic CL (ZCL), are induced by L. tropica and L. major, respectively [26]. Anthroponotic cutaneous leishmaniasis is restricted to the Old World [27]. The parasite L. tropica is principally transmitted by Phlebotomus sergenti. Although CL is distributed in 17 of the 31 provinces in Iran, about 80% of the total cases belong to ZCL, and the remaining cases are believed to be ACL [26, 28]. The latter is mainly urban and peri-urban and displays patterns of spatial clustering in many localities. The disease is generally characterized by large epidemics in heavily populated cities. Major foci of ACL are in southeastern parts of the country (Kerman and Bam counties), Yazd, Mashhad, and, to a smaller extent, in other provinces of Iran [26]. This focal dispersion of CL is merely in micro-ecological niches that affect the etiological agent, the reservoir host, and the primary vector [29]. Kerman province, where over 95% of the cases are caused by L. tropica, represents a major focus of ACL in Iran [30]. This disease represents an emergent threat with a high social and public health burden in the country. Over the past decades, several emerging ACL and ZCL epidemics of variable magnitudes [31,32,33,34,35] have occurred in different provinces of Iran. Migration, low economic status, natural disasters (drought, earthquakes, and flood), poverty-stricken suburbs of large cities, and cross-border movements are distinct risk factors for the emerging ACL epidemics [27, 36, 37].

The association between war and the emergence of CL is notably illustratted in Middle Eastern countries. During these wars, a wide range of risk-associated determinants such as population movement, the formation of new settlements, ecological disturbances, the collapse of control measures, and the breakdown of the health surveillance system have played a crucial role in the drastically increased incidence of CL in Syria, Saudi Arabia, Afghanistan, Lebanon, Libya, Iraq, and Turkey [24]. Currently, the disease has reached epidemic levels, affecting refugees in the involved zones. Of notable concern is CL’s long-term burden on conflict-ridden and previously endemic countries and particularly the role of CL in promoting severe poverty in such situations. As a result, the disease is now a large-scale global health concern. These outcomes have important health implications relevant to the prioritization of CL in global disease control strategies and research and development (R&D) needs, including diagnostic tools, drug innovations, and vaccine development [5].

This study aimed to assess an emerging epidemic focus of ACL in peri-urban areas of the city of Kerman in southeastern Iran. This focus has gradually been established, mainly because of the population movement and creation of new settlements. This investigation was undertaken because of political concerns, frequent earthquakes, and drought. Herein, the epidemiological, molecular, and phylogenetic profiles and associated public health impacts of the disease are explored.


Ethical considerations

The project (No. 92.448 and Ethics Code IR.KMU.REC.1392.413) was approved by the Ethics Committee of the Institutional Review Board (IRB) of Kerman University of Medical Sciences. The suspected CL cases were referred to the CL control clinic for diagnosis and free treatment. A brief face-to-face educational training was planned for each patient at the clinic to familiarize them with the disease consequences, proper management, and possible future relapses. Those who had underlying complications were referred to higher hospital levels to be further examined and managed accordingly. The patients only received a routine diagnosis and medication free of charge. The main reason why oral consent was acquired instead of written agreement was the illiteracy of most participants. No attempt was made to obtain written informed consent because of the possibility of the participant’s refusal to participate.

Study area

The province of Kerman is located between 30°16'59.56"N and 57°4'43.64"E and is the largest province in Iran with an area of 183,285 km2 and a population of 3,200,000. This province is located in the southeastern part of the country, 1000 km from Tehran (Fig. 1). The climate is diverse and directly influenced by two distinct types of climatic conditions: the southern areas include Bam, which is hot in summer (42 °C) and has a moderate climate in winter (25 °C), while the northern parts include Kerman city and the neighboring counties, with a mild and arid climate and a minimum and maximum temperature of − 7 °C and 40 °C, respectively. Such a varied range of climatic conditions creates suitable conditions for agricultural activities. This province alone supports approximately 25% of the country’s gardens. The above microclimatic zones and fertile land create appropriate conditions favoring CL proliferation.

Fig. 1

The affected peri-urban areas located in the southeastern part of Kerman city, southeastern Iran

The peri-urban area was home to 18,968 inhabitants in 2019 and consisted of two complex localities, Baghsarasiab, and Sharak Sannati (Table 1 and Fig. 1). Most migrants (80%) gradually arrived in this peri-urban area either from ACL endemic areas such as Bam and neighboring counties and non-endemic counties such as Jiroft, Zarand, and Sirjan.

Table 1 Population composition of the peri-urban area in the southeastern part of the city of Kerman, southeastern Iran, 2019

Data collection and sampling

This descriptive-analytical study was undertaken from July 2005 to December 2019 in the peri-urban area, and the data of the patients were compared with those obtained from the residents of the city of Kerman, the adjacent endemic city, where ACL has long been endemic. Pre-2005, data were not available as there was no well-recorded registry and referral system for CL patients to be documented and systematically managed. A general health clinic in charge of primary health care (PHC) services has previously been assigned in the peri-urban area (at the Sarasiab location). To determine this peri-urban area's population, a repeated census house-to-house visit is undertaken yearly by the health personnel. Subjects are passively referred to the health clinic to be screened for CL and other diseases. The peri-urban migrants who had resided in the area for at least 3 months were included. However, immigrants who left the peri-urban area within 3 months were excluded. Moreover, those settlers who had initial scars or a history of skin lesion(s) and were diagnosed with CL infection upon direct smear preparation were excluded from the study.

Every subject underwent a thorough physical examination of all body areas. The suspected cases were referred to Dadbin Health Clinic as the main registry center for managing CL cases. This health clinic has directly affiliated with the Leishmaniasis Research Center and School of Medicine. For each subject, a case report form (CRF) designating demographic (age, sex, and nationality) and clinical data (anatomical location and number of lesions, and treatment outcome) was recorded. In addition to direct smear preparation for all cases, clinical specimens were randomly selected for further molecular, sequencing, and phylogenetic analyses.

Clinical samples

Clinical smears were prepared from the CL-positive cases using a scalpel and blade from the margin of each lesion. Smear preparations were dried, fixed, and routinely stained by Giemsa and examined for Leishman bodies (amastigotes) under a conventional optical microscope with high dry magnification (1000×) [38].

Molecular identification

DNA extraction

Altogether, 50 positive microscopic slides were randomly selected, cleaned by xylol, and placed into a 1-ml cell lysis buffer. Smear preparations were entirely scraped with a sterile scalpel and blade [39]. For identification of the causative species, the genomic DNA was extracted from previously prepared slides using DNeasy Blood and Tissue Kits (Qiagen, Germany) according to the manufacturer’s instruction. The extracted DNA was stored at − 20 °C for polymerase chain reaction (PCR) assays. Previously, over 900 isolates were identified to the species level from this peri-urban area and the city of Kerman [40,41,42].

PCR analysis

Specimens were analyzed using the following forward and reverse ITS1-PCR primers as previously described with minor modifications: LITSR (5'-CTG-GAT-CAT-TTT-CCG-ATG-3') and L5.8S(5'-TGA-TAC-CAC-TTA-TCG-CAC-TT-3') [43, 44]. In brief, the thermal profile included three min at 94°C (primary denaturation), followed by 38 cycles of 30 s at 95 °C (denaturing), 35 s at 53 °C (annealing), and 45 s at 72 °C (extension), and a final extension step for 5 min at 72 °C. Polymerase chain reaction-specific amplification was confirmed by electrophoresing 5 µl of the reaction mix on 1% agarose gel containing ethidium bromide.

RFLP analysis of the ITS1 PCR

Restriction fragment length polymorphism (RFLP) analysis was performed to exploit variations in DNA sequences for the 7SL RNA region to pinpoint the locations of genes with a specific sequence. PCR products were digested with HaeIII enzyme, based on the manufacturer’s protocol. The fragments were analyzed in 3% agarose gel by electrophoresis and visualized with ethidium bromide using UV light.

Sequencing and phylogenetic analyses

Products of 18 randomly selected specimens were sequenced for the 7SL RNA region by Semiconductor Co., Ltd. Seoul, Korea. Sequences were trimmed by Sequence Scanner version 1 (Applied Biosystems Inc., Waltham, MA, USA). Multiple sequence alignments were analyzed using BioEdit program version 6. Molecular data were the basis for constructing the phylogenetic tree using MEGA version 7 [45].

Statistical analysis

Data were analyzed using SPSS 22 (Chicago, IL, USA) with χ2 testing to evaluate the significance of the difference between proportions. Potential demographic and clinical characteristics for patients with ACL were assessed. The incidences (new cases) of ACL among different age groups, genders, nationalities, anatomical locations, number of lesions, and treatment outcome were evaluated for the peri-urban area and the city of Kerman. The odds ratio (OR) is the ratio of the new cases in the peri-urban area to those of the city of Kerman between 2005 and 2019. P-value < 0.05 was considered statistically significant.


Epidemiological data

Cutaneous leishmaniasis patients were categorized into five 3-year periods to display the incidence rate of cases (Table 2 and Fig. 2a). Following the earthquake that struck Bam in 2003, the incidence rate of ACL cases significantly increased (P < 0.001) from 2005 to 2016 in new settlements with a sudden decline thereafter. The overall average risk of contracting the disease in peri-urban areas was 7.6 times higher in new settlements compared to the city of Kerman (Fig. 3).

Table 2 Baseline data indicating the new cases with anthroponic cutaneous leishmaniasis and the corresponding population in the peri-urban area compared with the city of Kerman, southeastern Iran, 2005–2019
Fig. 2

Incidence rates of new anthroponotic cutaneous leishmaniasis (ACL) cases (a), anatomical sites of the lesion in patients (b), number of lesions in patients (c) and treatment outcome of the patients (d) with ACL in the peri-urban area compared with the city of Kerman, southeastern Iran, 2005–2019

Fig. 3

Representative pictures of anthroponotic cutaneous leishmaniasis (ACL) cases obtained from Kerman and Bam cities (ag localized skin lesions; h lupoid leishmaniasis; i a chronic/unresponsive cutaneous lesion)

All age groups were affected in peri-urban areas, but the majority of cases occurred in the < 10 year age group (P < 0.001) (Table 3). The overall incidence rate was 3.3 and 0.44 per 10,000 inhabitants in the peri-urban area and Kerman city, respectively. There was a significant difference (P < 0.001) among the new cases in the two populations. Similarly, if the age group differences were considered, the incidence rate of infection in the < 10 year olds (5.3 vs. 0.58) was significantly higher (P < 0.001) than it was in the > 10 years age group (2.8 vs. 0.33) per 10,000 people in the peri-urban area and the city of Kerman, respectively (Fig. 2a). The rate of infection in Afghan migrants was significantly higher than in the Iranian nationals in the peri-urban community (P < 0.001). Conversely, the pattern of infection in the Afghan population was substantially higher (P < 0.001) relative to the Iranian residents in the city of Kerman. There was no significant difference among males and females in either the peri-urban area or in Kerman city.

Table 3 Demographic characteristics of the patients with anthroponotic cutaneous leishmaniasis in the peri-urban area and the city of Kerman, southeastern Iran, 2005–2019

Most of the patients were Iranian (n = 762, 89.7% vs. n = 4238, 90.5%) and to lesser extent Afghan migrants (n = 87, 10.3% vs. n = 445, 9.5%) in the peri-urban area and in the city of Kerman, respectively.

Clinical data

The anatomical locations of the skin lesions were slightly different between the suburban area and Kerman city, but the difference was not significant. The hands were the most common site of involvement (47.5% vs. 48.1%) followed by the face (29.6% vs. 26.7%) and legs (9.1% vs. 9.7%), and the others (13.8% vs. 15.5%) were located on other parts of the body in the peri-urban area and Kerman city, respectively (Fig. 2b). Most patients in the suburban area and the city of Kerman had a single lesion (69.4% vs. 62.5%) or two lesions (19.6% vs. 21.1%), and the rest (11.0% vs. 16.4%) had ≥ 3 lesions, respectively (Fig. 2c). The average number of skin lesions was 1.5.

Treatment outcome

Altogether, n = 5532 patients with CL received intralesional meglumine antimoniate along with biweekly liquid nitrogen cryotherapy or intramuscular meglumine antimoniate alone according to the national protocol. Post-treatment follow-up assessments were carried out at 3 months after completion of therapy. Of those, 84.9% vs. 85.2% were cured and 15.1% vs. 14.8% failed equally in the peri-urban area and Kerman city, respectively (Fig. 2d).

Molecular data

The ITS1 PCR amplified a 330-bp gene fragment on 2% agarose gel electrophoresis. All 50 randomly selected clinical isolates were confirmed to be purely L. tropica, the etiological parasite of urban CL in the Old World (Fig. 4).

Fig. 4

Digestion with the restriction endonuclease enzyme HaeIII of amplified ITS1 regions. Fragments were separated on 3% agarose gel electrophoresis to document differences in RFLP patterns with two bands of 185 and 58 bp for Leishmania tropica. Positive control samples (L. tropica and L. major), no enzymatic digestion isolates 330 bp (C), and representative clinical samples of anthroponotic cutaneous leishmaniasis (ACL) cases obtained from peri-urban areas, southeastern Iran [1,2,3,4,5,6,7]

Phylogenetic profile

After confirmation through PCR-RFLP, 18 sequenced amplicons of the 7SL RNA gene were used for phylogenetic analysis. Randomly selected nucleotide sequences were clustered into six variants and submitted to the GenBank database (KT279392-KT279397) (Fig. 5).

Fig. 5

Maximum likelihood phylogenetic tree of Leishmania tropica isolated from the peri-urban area, southeastern Iran

The numbers presented at the internodes indicate bootstrap support percentages (1000 replicates). To identify the type of isolated strains, at least three reference sequences were selected from each Leishmania species, using the list of WHO Leishmania reference strains. Accession numbers of isolated clinical samples in this study were also noted at the tips of the corresponding branches. All Kerman isolates in the current investigation were confirmed to belong to the L. tropica complex; however, a significant phylogenetic distance was observed with previous records of the province (MG694382 and MH632168). The accession number and species name of the sequences are given at the tips of the consistent branches, and the dissimilarity scale is portrayed at the bottom left corner in replacements per nucleotide.


In this study, we described a long-lasting emerging epidemic of ACL in peri-urban areas of the city of Kerman. The average risk of contracting ACL was significantly higher in new settlements than in Kerman city between 2005 and 2019. Kerman is a geographically vast, ecologically diverse, and topographically disaster-prone eco-region, and CL is a poverty-driven disease. Therefore, such a combination provides various ecological and biological risk factors in favor of emerging CL epidemics. This disease is considered the most emerging and re-emerging disease, which has recently increased to a hyperendemic level in some countries and extended its traditional territories to new foci [5, 46]. This is mainly due to the coexistence of complex determinants reinforcing suitable conditions for the proliferation of female Ph. sergenti flies and transmission of the causative agent, L. tropica, from human to human.

Furthermore, several massive earthquakes have stricken cities in the province, including Bam, Zarand, and Ravar counties, leaving behind approximately 40,000 survivors, 35,000 injured, and 60,000 homeless people. Moreover, the province has experienced severe droughts and rapid urbanization; therefore, varying arrays of relevant risk factors have been provided, negatively affecting health and resulting in multiple social, economic, and environmental consequences [41, 42, 47,48,49]. The last 2 decades have witnessed a massive migration from the peripheral counties and communities to the peri-urban areas of Kerman city, mostly attributed to prolonged droughts and natural disasters. Migrants reside in peri-urban shantytowns, built-in proximity to Kerman city, where the land is inexpensive. Still, they have to grapple with severe socioeconomic conditions and poor health services.

Population movements are strongly associated with the spread of neglected tropical diseases, particularly leishmaniasis, and are often exacerbated by poor medical services and insufficient sanitary infrastructures. Leishmaniasis is an example of the consequences engendered by population mobility. Based on the International Organization for Migration, > 200 million people are reported to be global migrants, and in about 52 countries, approximately 30 million are displaced within their own countries as the outcome of civil war and conflict, not to mention those recently driven away from their homes by famines, droughts, floods, and various other natural and human-made disasters [50].

Iran is home to diverse ethnic groups and has recently faced multiple health concerns. It is estimated that approximately 3 million Afghan people live in Iran because of the prolonged and ongoing civil war, violence, and political and socioeconomic instability in their homeland. Most of these migrants intended to engage in different professions temporarily but, for the most part, ultimately became permanent residents of the country. Kerman province has fertile and cultivable land and is among the three major agricultural provinces where many seasonal and permanent laborers, either indigenous or Afghan (~ 300,000) migrants, work in gardens and crop fields. However, different typographies and patterns of residency and mobility exist in the province; generally, most migrants are poor, and their living and working conditions have created a suitable environment for CL transmission.

Moreover, the cross-border movement from neighboring countries is a major challenge for a comprehensive CL control program. Iran has one of the longest borders [2, 6] with neighboring countries in Western Asia. The migration of many people from Afghanistan, Pakistan, and Iraq to Iran, where the conditions are suitable for the spread of the parasite, vector, and reservoir, could further propagate the disease. When a country shares long borders with multiple countries, cross-border movements are a common problem. A remarkable example of such a situation is the Syrian migrant crisis, which is the largest refugee and dislocation crisis of the century. Approximately 6 million Syrians are refugees, and about 6 million people are displaced within Syria. A population of over 12 million in Syria requires charitable support. At least 50% of the people involved in the Syrian refugee crisis are children. Health clinics and hospitals, financial institutions, schools, universities, and sanitation systems have been seriously hampered or demolished. Once busy markets have been devastated. War has destroyed the infrastructures, businesses, and social ties that bind people to their community. This ongoing civil war has aggravated old endemic CL foci to an epidemic state. It has increased the number of new cases of CL and the growth of the disease to new foci nationally and abroad [51].

The past few decades of civil conflict, war, and social unrest have hindered attempts to control ACL in Afghanistan. As a result, this country has been experiencing a prolonged epidemic [14]. Kabul has recently been reported to be the world’s most extensive ACL endemic focus [50, 51]. The persistence of the epidemic was associated with the continuous flow of immigrants, providing a constant reservoir of non-immune individuals [14]. Moreover, in Pakistan, refugees transmitted ACL into previously unaffected areas where a large urban CL outbreak in the refugee camp was recorded [52]. The primary mechanism is the displacement of the population into new settlements, where they become exposed to the source of infection where the biological vectors breed; either the migrating people arrive into new endemic areas and contract the disease through female sandfly bites or they carry the ACL infection as the main reservoir host and transmit the parasite to the unexposed population. Historical examples are the intrusion of ACL into different rural areas within this province following the earthquake, population flow, rapid unplanned urbanization, and fast and extensive road building in the last decade [31, 32, 35].

Leishmaniasis is a climate-sensitive complication, and fluctuations in precipitation, humidity, and temperature have a profound effect on the ecology, spread, and biodiversity of sandflies and reservoir hosts, impacting their distribution and hence facilitating the transmission of the causative parasite. During the last decades, profound droughts, devastating earthquakes, and frequent floods have had severe direct and indirect detrimental effects on groundwaters, rangelands, and agricultural crop productions. As a result of such alterations in Kerman province, many people (65,000 citizens) have lost their jobs and abandoned their villages. Such social and economic forces were the primary driverss that forced them to leave their occupations, which led to massive displacement and large-scale migration of the population to various cities and new peri-urban areas with high potential for ACL transmission [53].

Generally, the problem of peri-urban residents has been overlooked in the mainstream delivery of not only PHC services globally [54] but also essentials for standards of living. The peri-urban settlement adjacent to the city of Kerman has become a newly emerging ACL focus and an important concern in the epidemiology of ACL. Ph. sergenti has become widely dispersed as the principal vector of ACL in this area [55, 56]. In Iran, ACL is caused by L. tropica, which is mainly limited to humans [26], although sporadic cases of dogs being infected with ACL have been reported in this emerging focus [57, 58]. The actual role of dogs in the life-cycle of the parasite is not well known. It is assumed that they might be implicated in the urban life-cycle and play a secondary role in transmitting the L. tropica parasite [59].

The incidence of infection was analyzed. Although L. tropica infected all age groups, most cases occurred in children younger than 10 years in both the pre-urban area and Kerman city (5.3 vs. 0.58 per 10,000 population, respectively). These results are in agreement with the previous findings reported by others [60, 61]. Generally, children are less disciplined about covering themselves at night; they spend more time outdoors and hence are more frequently exposed to female sandfly bites than other people. Furthermore, children are at a higher risk of clinical disease due to their immature immune systems and are most easily infected by CL [62]. Peri-urban settlements under poor socioeconomic conditions increase the risk of CL. Impoverished domestic sanitary conditions and unsuitable housing environments, including open sewage or lack of solid waste management, might enhance sandfly resting and breeding sites and facilitate the transmission of the disease to humans. The lack of personal protection measures, civil unrest, disasters, and economically driven migration bring non-immune humans into contact with infected sandflies [63]. Public investment in management and control strategies would reduce the disease burden and help alleviate poverty [64].

Skin lesions can be either single or multiple on the hands, face, or other parts of the body. The exact reason for sizeable solitary lesions on the hands as the predominant involvement site is not well understood. This could be due to various environmental and behavioral factors associated with human habitation, parasites, and vector species. These results are also consistent with previous findings reported from these areas [35, 41]. This finding is consistent with the results found in the southeastern part of Iran [35, 65]. In contrast, in the previous report [60], the face was the most common site of involvement, followed by the hands and other body parts.

In Iran, meglumine antimoniate is the drug of choice for the treatment of ACL and is used either by intralesional administration in combination with cryotherapy or systemically alone based on the national guideline. The efficacy of both treatment regimens was in agreement with those reported from the southeast in the pre-urban area and also in the city of Kerman. Like in the city of Kerman, CL is passively detected in residents in the peri-urban area. Those who are suspected of being infected are referred to the CL management unit at Dadbin Clinic to be diagnosed and treated accordingly. Treatment failure is a common occurrence in Iran, particularly in endemic foci where ACL is prevalent, ranging between 10% and 15 % [41].

One of the secondary objectives of the current study was to identify the causative parasite and analyze the genetic variability of L. tropica isolates obtained from patients with ACL. Among all Leishmania genus species, L. tropica shows a high level of genetic polymorphism [43]. Applying the highly sensitive and powerful diagnostic technique directly from clinical samples could be an important tool for identifying the species and determining the disease's geographical distribution. This could be a fundamental approach to planning future control programs [4]. In this study, the implementation of PCR-RFLP analyses of the ribosomal ITS1 amplicons followed by partial 7SL RNA sequencing revealed different heterogeneity patterns compared to the national and international isolates. Overall, six genetic variants were detected among the sequenced isolates.

The existence of different L. tropica genotypes in the city and peri-urban areas highlights the high levels of heterogeneity of this species within the study area in the province of Kerman. These variants were closely related and clustered together with other previous isolates obtained from Bam and Kerman counties [30, 35, 66]. The overall pattern of ACL infection indicates that the etiological agent of ACL is propagated and transmitted from person to person from dissimilar clones as reflected by the complexity of the migrants’ backgrounds. This finding also showed that different haplotypes are presumably associated with various clinical features that respond differently to conventional drugs [41, 61]. Efforts to compare the phylogenetic results with clinical isolates from Afghanistan were inconclusive as no 7SL RNA gene analysis was available in the literature.

Several gene regions, including ITS1, 7SLRNA, and Hsp70 sequences, have been used to compare the genetic diversity among non-healed and healed isolates of ACL cases in the main foci in Iran [66]. Among the three gene regions, 7SLRNA and Hsp70 were genetically identical, while the ITS1 region showed nucleotide heterogeneity patterns between the unresponsive and responsive forms. Hence, the ITS1 genetic marker could serve to inspire further future investigations on the function of these variations among different non-healing clinical forms of patients with ACL. The VL caused by L. tropica was also revealed to be genetically heterogeneous [67] and to play a key role in the generation of drug-resistant leishmaniasis recidivans in the southeastern part of Iran [68]. Leishmania tropica isolates in the southeast (Kerman and Bam counties) represented different genetic polymorphisms using PCR-RFLP of the kinetoplast DNA (kDNA) [67].

Toz and colleagues have already used real-time PCR as a powerful and prevailing tool to identify clinical samples [69]. Giemsa-stained slides are valuable sources to be used for PCR for the identification of Leishmania isolates to the species level. In the present study, all isolates were L. tropica, the causative agent of urban CL in the Old World. Previous studies also employed ITS1 PCR on clinical smear preparations for Leishmania species identification [60, 70]. Such a molecular tool provides fundamental approaches to understanding the epidemiological characteristics in order to select the disease’s proper treatment modality [71].

Population displacement and migration are rapidly becoming issues of public health concern; they require particular policy attention at many levels in developing countries. The provision of all the essentials to such unprepared communities is not possible. Problems of peri-urban settlements have been somewhat overlooked in the process of service delivery. A robust commitment to a multilateral approach is crucial to making improvements in this area. This will require decisive coordinated actions through all governmental factions, including policymakers, health professionals, senior researchers, and non-governmental organizations (NGOs).

There has been no study similar to this work to the best of our knowledge, and it is the largest observation carried out on a vulnerable peri-urban community where population mobilization is directly associated with CL. This investigation’s major strength is assessing a long-lasting emerging CL epidemic for 15 years, with many cases. This achievement is mainly due to the well-coordinated work, carried out by expert academic members, linked with a team of experienced health personnel and staff. This study has also drawn attention to the importance of population mobility to CL as a major neglected tropical disease in a highly endemic country.

The current investigation had many limitations. First, although CL is a notifiable disease in Iran, cases are only detected through passive strategies. Implementation of active case-finding approaches could help assess the actual burden of the disease for planning future control programs. Second, due to the complexity of the population and the presence of so many environmental and socio-cultural determinants, it was not feasible to provide comprehensive advice. Third, methodologically, such studies are complex and challenging as they assess interactions of health and population movements over large distances and relatively long periods. This requires large multicenter and multidisciplinary projects. Consequently, multiple studies exploring the local cases and challenges to health care services related to mobile populations are essential.

In conclusion, the movement of populations and the establishment of new settlements in peri-urban areas in close association with endemic areas are major risk factors and are directly linked to the occurrence of CL, either contributing to exposure of the vulnerable and at-risk population to new risks or leading to the introduction of the causative agent into new areas. The risk of contracting ACL is further exacerbated by poor socioeconomic backgrounds and lack of adequate health infrastructures in the new settlement. Therefore, public health surveillance systems and clinical practitioners should know the new settlement’s basic needs. Furthermore, promoting public awareness, directly or by social media, mainly in high-risk areas where the disease is notifiable, active and passive case detection strategies, early diagnosis, and effective treatment modalities could help control the disease. Besides, public investment in infrastructures, management, and control strategies will reduce the disease burden and alleviate poverty.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.



Cutaneous leishmaniasis


Anthroponotic cutaneous leishmaniasis


Internal transcribed spacer1


Polymerase chain reaction


Restriction fragment length polymorphism


Visceral leishmaniasis


Mucocutaneous leishmaniasis


Zoonotic cutaneous leishmaniasis


Institutional review board


  1. 1.

    Bailey F, Mondragon-Shem K, Haines LR, Olabi A, Alorfi A, Ruiz-Postigo JA, et al. Cutaneous leishmaniasis and co-morbid major depressive disorder: a systematic review with burden estimates. PLoS Negl Trop Dis. 2019;13(2):e0007092.

    PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    Bilgic-Temel A, Murrell DF, Uzun S. Cutaneous leishmaniasis: a neglected disfiguring disease for women. Int J women’s dermatology. 2019;5(3):158–65.

    Article  Google Scholar 

  3. 3.

    World Health Organization. Leishmaniasis factsheet. Geneva: World Health Organization; 2020.

    Google Scholar 

  4. 4.

    Alvar J, Vélez ID, Bern C, Herrero MM, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE. 2012;7(5):e35671.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  5. 5.

    Bailey F, Mondragon-Shem K, Hotez P, Ruiz-Postigo JA, Al-Salem W, Acosta-Serrano Á, et al. A new perspective on cutaneous leishmaniasis—Implications for global prevalence and burden of disease estimates. PLoS Negl Trop Dis. 2017;11(8):e0005739.

    PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    World Health Organization. Leishmaniasis. Geneva: World Health Organization; 2020.

    Google Scholar 

  7. 7.

    Jaafari MR, Hatamipour M, Alavizadeh SH, Abbasi A, Saberi Z, Rafati S, et al. Development of a topical liposomal formulation of amphotericin B for the treatment of cutaneous leishmaniasis. Int J Parasitol Drugs Drug Resist. 2019;11:156–65.

    PubMed  PubMed Central  Article  Google Scholar 

  8. 8.

    Gunay F, Karakus M, Oguz G, Dogan M, Karakaya Y, Ergan G, et al. Evaluation of the efficacy of Olyset® Plus in a village-based cohort study in the Cukurova Plain, Turkey, in an area of hyperendemic cutaneous leishmaniasis. J Vector Ecol. 2014;39(2):395–405.

    PubMed  Article  Google Scholar 

  9. 9.

    World Health Organization. Framework for a National Vector Control Needs Assessment. Geneva: WHO; 2017. p. 48.

    Google Scholar 

  10. 10.

    Alten B, Maia C, Afonso MO, Campino L, Jiménez M, González E, et al. Seasonal dynamics of phlebotomine sand fly species proven vectors of Mediterranean leishmaniasis caused by Leishmania infantum. PLoS Negl Trop Dis. 2016;10(2):e0004458.

    PubMed  PubMed Central  Article  Google Scholar 

  11. 11.

    Kato H, Gomez EA, Seki C, Furumoto H, Martini-Robles L, Muzzio J, et al. PCR-RFLP analyses of Leishmania species causing cutaneous and mucocutaneous leishmaniasis revealed distribution of genetically complex strains with hybrid and mito-nuclear discordance in Ecuador. PLoS Negl Trop Dis. 2019;13(5):e0007403.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  12. 12.

    Anversa L, Tiburcio MGS, Richini-Pereira VB, Ramirez LE. Human leishmaniasis in Brazil: a general review. Rev Assoc Med Bras. 2018;64(3):281–9.

    PubMed  Article  Google Scholar 

  13. 13.

    da Paixão SA, Mao L, Galvis-Ovallos F, Lima JMT, Valle D. Risk analysis and prediction of visceral leishmaniasis dispersion in São Paulo State, Brazil. PLoS Negl Trop Dis. 2017;11(2):e0005353.

    Article  Google Scholar 

  14. 14.

    Reyburn H, Rowland M, Mohsen M, Khan B, Davies C. The prolonged epidemic of anthroponotic cutaneous leishmaniasis in Kabul, Afghanistan:‘bringing down the neighbourhood.’ Trans R Soc Trop Med Hyg. 2003;97(2):170–6.

    PubMed  Article  Google Scholar 

  15. 15.

    Aoun K, Bouratbine A. Cutaneous leishmaniasis in North Africa: a review. Parasite. 2014;21:14.

    PubMed  PubMed Central  Article  Google Scholar 

  16. 16.

    Muhjazi G, Gabrielli AF, Ruiz-Postigo JA, Atta H, Osman M, Bashour H, et al. Cutaneous leishmaniasis in Syria: a review of available data during the war years: 2011–2018. PLoS Negl Trop Dis. 2019;13(12):e0007827.

    PubMed  PubMed Central  Article  Google Scholar 

  17. 17.

    Al-Bajalan MMM, Al-Jaf SMA, Niranji SS, Abdulkareem DR, Al-Kayali KK, Kato H. An outbreak of Leishmania major from an endemic to a non-endemic region posed a public health threat in Iraq from 2014–2017: Epidemiological, molecular and phylogenetic studies. PLoS Negl Trop Dis. 2018;12(3):e0006255.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  18. 18.

    Alkulaibi MM, Suleiman AM, Gasim Khalil EA, Al-Garadi MA. Prevalence of cutaneous leishmaniasis in Western Highlands in Yemen. J Trop Med. 2019;2019:8248916.

    PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Collis S, El-Safi S, Atia AA, Bhattacharyya T, Hammad A, Den Boer M, et al. Epidemiological and molecular investigation of resurgent cutaneous leishmaniasis in Sudan. Int J Infect Dis. 2019;88:14–20.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  20. 20.

    El Hamouchi A, Daoui O, Kbaich MA, Mhaidi I, El Kacem S, Guizani I, et al. Epidemiological features of a recent zoonotic cutaneous leishmaniasis outbreak in Zagora province, southern Morocco. PLoS Negl Trop Dis. 2019;13(4):e0007321.

    PubMed  PubMed Central  Article  Google Scholar 

  21. 21.

    Abuzaid AA, Abdoon AM, Aldahan MA, Alzahrani AG, Alhakeem RF, Asiri AM, et al. Cutaneous leishmaniasis in Saudi Arabia: a comprehensive overview. Vector-Borne Zoonotic Dis. 2017;17(10):673–84.

    PubMed  PubMed Central  Article  Google Scholar 

  22. 22.

    Al-Salem WS, Pigott DM, Subramaniam K, Haines LR, Kelly-Hope L, Molyneux DH, et al. Cutaneous leishmaniasis and conflict in Syria. Emerg Infect Dis. 2016;22(5):931.

    PubMed  PubMed Central  Article  Google Scholar 

  23. 23.

    Özden S. Syrian refugees in Turkey. 2013.

  24. 24.

    Çizmeci Z, Karakuş M, Karabela ŞN, Erdoğan B, Güleç N. Leishmaniasis in Istanbul; a new epidemiological data about refugee leishmaniasis. Acta Trop. 2019;195:23–7.

    PubMed  Article  Google Scholar 

  25. 25.

    Turktan M, Ak O, Erdem H, Ozcengiz D, Hargreaves S, Kaya S, et al. Community acquired infections among refugees leading to Intensive Care Unit admissions in Turkey. Int J Infect Dis. 2017;58:111–4.

    PubMed  Article  Google Scholar 

  26. 26.

    Shirzadi MR, Esfahania SB, Mohebalia M, Ershadia MRY, Gharachorlo F, Razavia MR, et al. Epidemiological status of leishmaniasis in the Islamic Republic of Iran, 1983–2012. East Mediterr Heal J. 2015;21(10):736–42.

    CAS  Article  Google Scholar 

  27. 27.

    Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg. 2001;95(3):239–43.

    CAS  PubMed  Article  Google Scholar 

  28. 28.

    Shirzadi MR, Gouya MM. National Guidelines for cutaneous leishmaniasis surveillance in Iran. Minist Heal Med Educ (MOH) Zoonoses Control Dep Tehran Iran pp. 2012; 1–78.

  29. 29.

    Postigo JAR. Leishmaniasis in the world health organization eastern mediterranean region. Int J Antimicrob Agents. 2010;36:S62–5.

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Ramezany M, Sharifi I, Babaei Z, Ghasemi Nejad Almani P, Heshmatkhah A, Keyhani A, et al. Geographical distribution and molecular characterization for cutaneous leishmaniasis species by sequencing and phylogenetic analyses of kDNA and ITS1 loci markers in south-eastern Iran. Pathog Glob Health. 2018;112:1–10.

    Article  CAS  Google Scholar 

  31. 31.

    Sharifi I, Poursmaelian S, Aflatoonian MR, Ardakani RF, Mirzaei M, Fekri AR, et al. Emergence of a new focus of anthroponotic cutaneous leishmaniasis due to Leishmania tropica in rural communities of Bam district after the earthquake Iran. Trop Med Int Heal. 2011;16(4):510–3.

    Article  Google Scholar 

  32. 32.

    Aflatoonian MR, Sharifi I, Poursmaelian S, Hakimi-Parizi M, Ziaali N. The emergence of anthroponotic cutaneous leishmaniasis following the earthquake in southern villages of Bam district, southeastern Iran, 2010. J Arthropod Borne Dis. 2013;7(1):8–14.

    PubMed  PubMed Central  Google Scholar 

  33. 33.

    Mirzaei M, Sharifi I, Poursmaelian S. A new focus of anthroponotic cutaneous leishmaniasis and identification of parasite species by nested PCR in Jiroft Iran. Comp Clin Path. 2012;21(5):1071–5.

    Article  Google Scholar 

  34. 34.

    Pouresmaeelian S, Sharifi I, Aflatoonian MR. A new focus of anthroponotic cutaneous leishmaniasis in Dehbakry region of Bam district, southeastern Iran 2008. J Kerman Univ Med Sci. 2015;17(1):15–24.

    Google Scholar 

  35. 35.

    Razavinasab SZ, Sharifi I, Aflatoonian MR, Babaei Z, Mohammadi MA, Salarkia E, et al. Expansion of urban cutaneous leishmaniasis into rural areas of southeastern Iran: clinical, epidemiological and phylogenetic profiles explored using 7SL high resolution melting-PCR analysis. Transbound Emerg Dis. 2019;66(1):1602–10.

    PubMed  Google Scholar 

  36. 36.

    Desjeux P. Worldwide increasing risk factors for leishmaniasis. Med Microbiol Immunol. 2001;190(1):77–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  37. 37.

    Du R, Hotez PJ, Al-Salem WS, Acosta-Serrano A. Old world cutaneous leishmaniasis and refugee crises in the Middle East and North Africa. PLoS Negl Trop Dis. 2016;10(5):e0004545.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  38. 38.

    Khademvatan S, Neisi N, Maraghi S, Saki J. Diagnosis and identification of Leishmania spp. from Giemsa-stained slides, by real-time PCR and melting curve analysis in south-west of Iran. Ann Trop Med Parasitol. 2011;105(8):559–65.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  39. 39.

    Schönian G, Nasereddin A, Dinse N, Schweynoch C, Schallig HDFH, Presber W, et al. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis. 2003;47(1):349–58.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  40. 40.

    Sharifi I, Aflatoonian MR, Fekri AR, Parizi MH, Afshar AA, Khosravi A, et al. A comprehensive review of cutaneous leishmaniasis in Kerman province, southeastern iran-narrative review article. Iran J Public Health. 2015;44(3):299.

    PubMed  PubMed Central  Google Scholar 

  41. 41.

    Aflatoonian MR, Sharifi I, Aflatoonian B, Bamorovat M, Heshmatkhah A, Babaei Z, et al. Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: a cohort study in Iran. PLoS Negl Trop Dis. 2019;13(6):e0007423.

    PubMed  PubMed Central  Article  Google Scholar 

  42. 42.

    Aflatoonian MR, Sharifi I, Parizi MH, Fekri AR, Aflatoonian B, Sharifi M, et al. A prospective cohort study of cutaneous leishmaniasis risk and opium addiction in south eastern iran. PLoS ONE. 2014;9(2):e89043.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  43. 43.

    Schönian G, Schnur L, El Fari M, Oskam L, Kolesnikov AA, Sokolowska-Köhler W, et al. Genetic heterogeneity in the species Leishmania tropica revealed by different PCR-based methods. Trans R Soc Trop Med Hyg. 2001;95(2):217–24.

    PubMed  Article  Google Scholar 

  44. 44.

    Mohammadi MA, Bamorovat M, Harandi MF, Karimi T, Sharifi I, Aflatoonian MR. Comparison of three PCR-based methods for simplicity and cost effectiveness identification of cutaneous Leishmaniasis due to Leishmania tropica. Iran J Parasitol. 2017;12(2):215.

    PubMed  PubMed Central  Google Scholar 

  45. 45.

    Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33(7):1870–4.

    CAS  Article  Google Scholar 

  46. 46.

    Bailey CJ. Under-treatment of type 2 diabetes: causes and outcomes of clinical inertia. Int J Clin Pract. 2016;70(12):988–95.

    PubMed  Article  Google Scholar 

  47. 47.

    Bamorovat M, Sharifi I, Aflatoonian MR, Sharifi H, Karamoozian A, Sharifi F, et al. Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran. PLoS ONE. 2018;13(2):e0192236.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  48. 48.

    Aghaei Afshar A, Hojjat F, Yaghoobi-Ershadi MR, Rassi Y, Akhavan AA, Gorouhi MA, et al. Modelling and evaluating the risk of zoonotic cutaneous leishmaniasis in selected areas of Kerman Province, south of Iran. Transbound Emerg Dis. 2020;67(3):1271–83.

    PubMed  Article  Google Scholar 

  49. 49.

    Oliaee RT, Sharifi I, Afgar A, Kareshk AT, Asadi A, Heshmatkhah A, et al. Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling. Trop Med Int Heal. 2018;23(6):622–33.

    CAS  Article  Google Scholar 

  50. 50.

    Aagaard-Hansen J, Nombela N, Alvar J. Population movement: a key factor in the epidemiology of neglected tropical diseases. Trop Med Int Heal. 2010;15(11):1281–8.

    Article  Google Scholar 

  51. 51.

    Carlson ED, Williams NE. Comparative Demography of the Syrian Diaspora: European and Middle Eastern Destinations, vol. 20. Berlin: Springer; 2020.

    Google Scholar 

  52. 52.

    Rowland M, Durrani N, Hewitt S, Mohammed N, Bouma M, Carneiro I, et al. Permethrin-treated chaddars and top-sheets: appropriate technology for protection against malaria in Afghanistan and other complex emergencies. Trans R Soc Trop Med Hyg. 1999;93(5):465–72.

    CAS  PubMed  Article  Google Scholar 

  53. 53.

    Motawef S, Asadi S. Migration After Natural Disasters, Case Study:\“the 2003 Bam Earthquake.” WIT Trans Ecol Environ. 2011;148:625–32.

    Article  Google Scholar 

  54. 54.

    Ngere I, Gufu Boru W, Isack A, Muiruri J, Obonyo M, Matendechero S, et al. Burden and risk factors of cutaneous leishmaniasis in a peri-urban settlement in Kenya, 2016. PLoS ONE. 2020;15(1):e0227697.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  55. 55.

    Aghaei Afshar A, Rassi Y, Sharifi I, Vatandoost H, Mollaie HR, Oshaghi MA, et al. First report on natural Leishmania infection of Phlebotomus sergenti due Leishmania tropica by high resolution melting curve method in Southeastern Iran. Asian Pac J Trop Med. 2014;7:93–6.

    CAS  PubMed  Article  Google Scholar 

  56. 56.

    Mozafary M, Dayer MS, Afshar AA, Mollaie HR. Molecular characterization of Leishmania parasites in naturally infected sand flies from the endemic focus of Kerman City, Southeastern Iran. Asian Pacific J Trop Dis. 2016;6(3):188–92.

    CAS  Article  Google Scholar 

  57. 57.

    Bamorovat M, Sharifi I, Dabiri S, Mohammadi MA, Harandi MF, Mohebali M, et al. Leishmania tropica in stray dogs in southeast Iran. Iran J Public Health. 2015;44(10):1359–66.

    PubMed  PubMed Central  Google Scholar 

  58. 58.

    Hajjaran H, Mohebali M, Zarei Z, Edrissian G. Leishmania tropica: another etiological agent of canine visceral leishmaniasis in Iran. Iran J Public Health. 2007;36(1):85–8.

    CAS  Google Scholar 

  59. 59.

    Bamorovat M, Sharifi I, Dabiri S, Mohammadi M, Fasihi Harandi M, Mohebali M, et al. Leishmania tropica in stray dogs in southeast Iran. Iran J Public Health. 2015;44(10):1359.

    PubMed  PubMed Central  Google Scholar 

  60. 60.

    Özkeklikçi A, Karakuş M, Özbel Y, Töz S. The new situation of cutaneous leishmaniasis after Syrian civil war in Gaziantep city Southeastern region of Turkey. Acta Trop. 2017;166:35–8.

    PubMed  Article  Google Scholar 

  61. 61.

    Khosravi A, Sharifi I, FekriI A, Kermanizadeh A, Bamorovat M, Mostafavi M, et al. Clinical features of anthroponotic cutaneous leishmaniasis in a major focus, Southeastern Iran, 1994–2014. Iran J Parasitol. 2017;12(4):544.

    PubMed  PubMed Central  Google Scholar 

  62. 62.

    Aksoy M, Doni N, Ozkul HU, Yesilova Y, Ardic N, Yesilova A, et al. Pediatric cutaneous leishmaniasis in an endemic region in Turkey: a retrospective analysis of 8786 cases during 1998–2014. PLoS Negl Trop Dis. 2016;10(7):e0004835.

    PubMed  PubMed Central  Article  Google Scholar 

  63. 63.

    World Health Organization. UNICEF. Global vector control response 2017–2030: A strategic approach to tackle vector-borne diseases 2017.

  64. 64.

    Alvar J, Yactayo S, Bern C. Leishmaniasis and poverty. Trends Parasitol. 2006;22(12):552–7.

    PubMed  Article  Google Scholar 

  65. 65.

    Askari A, Sharifi I, Aflatoonian MR, Babaei Z, Almani PGN, Mohammadi MA, et al. A newly emerged focus of zoonotic cutaneous leishmaniasis in South-Western Iran. Microb Pathog. 2018;121:363–8.

    CAS  PubMed  Article  Google Scholar 

  66. 66.

    Bamorovat M, Sharifi I, Mohammadi MA, Eybpoosh S, Nasibi S, Aflatoonian MR, et al. Leishmania tropica isolates from non-healed and healed patients in Iran: a molecular typing and phylogenetic analysis. Microb Pathog. 2018;116:124–9.

    CAS  PubMed  Article  Google Scholar 

  67. 67.

    Ghatee MA, Mirhendi H, Marashifard M, Kanannejad Z, Taylor WR, Sharifi I. Population structure of Leishmania tropica causing Anthroponotic Cutaneous Leishmaniasis in Southern Iran by PCR-RFLP of Kinetoplastid DNA. Biomed Res Int. 2018.

    Article  PubMed  PubMed Central  Google Scholar 

  68. 68.

    Sharifi I, Fekri AR, Aflatoonian MR, Khamesipour A, Mahboudi F, Dowlati Y, et al. Leishmaniasis recidivans among school children in Bam, South-east Iran, 1994–2006. Int J Dermatol. 2010;49(5):557–61.

    PubMed  Article  Google Scholar 

  69. 69.

    Toz SO, Culha G, Zeyrek FY, Ertabaklar H, Alkan MZ, Vardarlı AT, et al. A real-time ITS1-PCR based method in the diagnosis and species identification of Leishmania parasite from human and dog clinical samples in Turkey. PLoS Negl Trop Dis. 2013;7(5):e2205.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  70. 70.

    Al-Jawabreh A, Schoenian G, Hamarsheh O, Presber W. Clinical diagnosis of cutaneous leishmaniasis: a comparison study between standardized graded direct microscopy and ITS1-PCR of Giemsa-stained smears. Acta Trop. 2006;99(1):55–61.

    CAS  PubMed  Article  Google Scholar 

  71. 71.

    Uzun S, Gürel MS, Durdu M, Akyol M, Fettahlıoğlu Karaman B, Aksoy M, et al. Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey. Int J Dermatol. 2018;57(8):973–82.

    PubMed  Article  Google Scholar 

Download references


We thank the patients for their cooperation and the health personnel and staff at Dadbin Health Clinic, County, and Provincial Health Surveillance Systems for their help in performing this study.


This study was supported by the Kerman University of Medical Sciences, Kerman, Iran (no. 92.448). The funders had no role in the study design, data collection, analysis, and the decision to publish.

Author information




TK, IS, and MRA designed the experiments. BA, MAM, ES, ZB, FZ, FS, NH, AK, AE, ES, MS, MM, AH, RA, SF, AK, AA, AJ, and MB collected data and performed the experiments. MAM, ES, and AK contributed materials. TK, IS, AJ, MRA, BA, and MB analyzed the data. IS, MRA, SF, and MB wrote the draft. IS revised the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Iraj Sharifi or Mohammad Reza Aflatoonian.

Ethics declarations

Ethics approval and consent to participate

The Ethics Committee approved the project (no. 92.448 and Ethics Code, IR.KMU.REC.1392.413) of the Institutional Review Board (IRB) of Kerman University of Medical Sciences.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Karimi, T., Sharifi, I., Aflatoonian, M.R. et al. A long-lasting emerging epidemic of anthroponotic cutaneous leishmaniasis in southeastern Iran: population movement and peri-urban settlements as a major risk factor. Parasites Vectors 14, 122 (2021).

Download citation


  • Population movement
  • Cutaneous leishmaniasis epidemic
  • Phylogenetic analysis
  • Iran